General Information of Drug (ID: DMZ416B)

Drug Name
KD020 Drug Info
Indication
Disease Entry ICD 11 Status REF
Kidney disease GC2Z Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMZ416B

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Microsomal triglyceride transfer protein (MTTP) TTUS1RD MTP_HUMAN Modulator [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Microsomal triglyceride transfer protein (MTTP) DTT MTTP 8.358 4.828 4.644 9.121
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Kidney disease
ICD Disease Classification GC2Z
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Microsomal triglyceride transfer protein (MTTP) DTT MTTP 9.76E-02 0.13 0.68
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020855)
2 Clinical pipeline report, company report or official report of Kadmon Pharmaceuticals.